Showing results (1731-1740 of 1,763) with videos related to

Sort By:
Pageof 177
Spinal Cord|October 6, 2018
Correction: Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update and a new guidelineKathleen A Martin Ginis, Jan W van der Scheer, Amy E Latimer-Cheung, et al.
Drug and Alcohol Dependence|October 26, 2013
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteriaGeurt van de Glind, Maija Konstenius, Maarten W J Koeter, et al.
Spinal Cord|October 27, 2017
Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update and a new guidelineKathleen A Martin Ginis, Jan W van der Scheer, Amy E Latimer-Cheung, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activityKoji Shinoda, Rui Li, Ayman Rezk, et al.
Journal of Attention Disorders|February 29, 2016
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment SeekersSharlene Kaye, Josep Antoni Ramos-Quiroga, Geurt van de Glind, et al.
JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
The Canadian Journal of Cardiology|June 7, 2006
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - TherapyN A Khan, Finlay A McAlister, Simon W Rabkin, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
Journal of Neurochemistry|September 18, 2025
Embracing Scientific Debate in Brain MetabolismJens V Andersen, Blanca I Aldana, Lasse K Bak, et al.
Trials|May 5, 2021
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trialPhilippe Bégin, Jeannie Callum, Nancy M Heddle, et al.
Pageof 177